Company intelligence / Profile preview

Innovestor

Helsinki, Finlandinnovestorgroup.com ↗
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

Innovestor Life Science Fund is an active Finnish venture capital fund investing in early-stage biotech and digital health startups across the Nordics and Baltics. Its €90 million fund has backed at least 12–13 disruptive life science companies since 2022, including university spinouts developing novel therapies for neurological diseases and women’s health. Portfolio highlights include investments in Polku Therapeutics (neurodegeneration), Neumirna Therapeutics (RNA therapies for neurological disorders), and Gesynta Pharma (non-hormonal endometriosis treatment). The fund typically co-invests with international partners and supports preclinical through Phase II development[1][3][4][5].

Therapeutic areas
NeurologyWomen's Health
Modalities
Small moleculeRNA therapy
Industry
Investors
02

Partnerships

Co-investments with European & US specialist investors such as Hadean Ventures, Industrifonden, Linc, RH Capital, Catalyze Capitalacademic collaborations via university spinouts from University of Helsinki and others

Beyond the preview

Go deeper on Innovestor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovestor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call